Dr Christopher Henney joins Anthera
This article was originally published in Scrip
Anthera Pharmaceuticals, a private US biopharmaceutical company developing anti-inflammatory drugs, has appointed Dr Christopher Henney chairman. He has served as an independent director of Anthera since 2006. Dr Henney is a co-founder of three US biotechnology companies – Immunex, ICOS and Dendreon. Most recently he has served as chairman and CEO of Dendreon and as chairman of SGX Pharmaceuticals and of Oncothyreon.